bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Keros Therapeutics Inc. logo

    Keros Therapeutics Inc.

    KROS | NASDAQ
    Chart Builder DCF Calculator
    $11.71
    +$0.23 (+2.00%)
    Sep 22, 2026, 11:47 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $227.62M
    Enterprise Value
    $-14.27M
    Beta
    1.02
    Average Volume
    263.6K
    Shares Outstanding (Diluted)
    19.8M
    Shares Change YoY
    -51.25%
    Institutional Ownership
    94.73%
    Exchange
    NASDAQ
    ISIN
    US4923271013

    Price Performance

    Price Change 1M
    3.7%
    Price Change 3M
    4.4%
    Price Change 6M
    1.2%
    Price Change YTD
    -38.1%
    Price Change 1Y
    -27.8%
    Price Change 3Y
    -65.0%
    Price Change 5Y
    -65.2%
    1M CAGR (ann.)
    3.0%
    1Y CAGR (ann.)
    -28.4%
    5Y CAGR (ann.)
    -18.0%
    All-Time CAGR
    -8.3%

    Valuation

    PE Ratio
    -3.57
    Forward PE
    N/A
    PEG Ratio
    0.00
    Forward PEG
    -0.25
    PS Ratio
    15.16
    Forward PS
    16.60
    PB Ratio
    0.87
    P/FCF Ratio
    -4.69
    P/Adj. FCF Ratio
    -3.19
    P/OCF Ratio
    -4.74
    EV/Sales
    -0.95
    EV/EBIT
    0.17
    EV/EBITDA
    0.17
    EV/FCF
    0.29
    Earnings Yield
    -28.1%
    FCF Yield
    -21.3%
    Adj. FCF Yield
    -31.4%

    Financial Health

    Net Cash
    $241.88M
    Total Debt
    $15.72M
    Cash & Short-Term Investments
    $257.61M
    Total Assets
    $287.6M
    Current Ratio
    21.96
    Quick Ratio
    21.96
    Debt / Equity Ratio
    0.06
    Debt / EBITDA
    -0.19
    Debt / FCF
    -0.32
    OCF / Debt
    -3.05
    Interest Coverage
    0.00
    Altman Z-Score
    2.93
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    94.7%
    Operating Profit Margin
    -675.8%
    EBITDA Margin
    -562.8%
    Net Profit Margin
    -553.9%
    FCF Margin
    -322.9%
    Adj. FCF Margin
    -475.3%
    SBC / Revenue
    152.3%
    SBC Impact (per share)
    -47.2%

    Returns

    Return on Assets
    -28.9%
    Return on Equity
    -21.4%
    Return on Invested Capital
    -35.3%
    Return on Capital Employed
    -36.8%
    Return on Tangible Assets
    -28.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    8.9%
    Revenue CAGR 5Y
    172.5%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    38.8%
    EPS CAGR 5Y
    14.0%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    103.5%
    FCF CAGR 5Y
    29.9%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    17
    EPS Growth Next 3Y
    -312.5%
    Revenue Growth Next 3Y
    71.0%
    Earnings Date
    Nov 3, 2026
    EPS Estimate (next Q)
    -$0.96
    EPS Growth Est (next Q)
    433.3%
    Revenue Est (next Q)
    $14.76M
    Revenue Growth Est (next Q)
    3.5%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $20.33
    Price Target Upside
    77.1%

    Cash Flow

    Operating Cash Flow
    $-47.99M
    Free Cash Flow
    $-48.49M
    Adj. Free Cash Flow
    $-71.35M
    FCF Per Share
    -$2.45
    OCF Per Share
    -$2.42
    OCF/S Ratio
    -319.7%

    Income Statement

    Revenue
    $15.01M
    Gross Profit
    $14.22M
    Operating Income
    $-101.47M
    EBITDA
    $-84.5M
    Net Income
    $-83.16M
    EPS (Diluted)
    -$3.22
    Revenue / Employee
    $163.2K
    Profit / Employee
    $-903.9K
    Employees
    92

    © 2026 bestshares.com. All rights reserved.